Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$1.85B |
| 2 |
Burlington
BURL
|
+$1.01B |
| 3 |
Philip Morris
PM
|
+$781M |
| 4 |
JPMorgan Chase
JPM
|
+$679M |
| 5 |
General Motors
GM
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.71B |
| 2 |
Netflix
NFLX
|
+$1.61B |
| 3 |
Illumina
ILMN
|
+$1.2B |
| 4 |
Mercado Libre
MELI
|
+$1.12B |
| 5 |
Amazon
AMZN
|
+$976M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 19.04% |
| 3 | Communication Services | 14.79% |
| 4 | Consumer Discretionary | 12.62% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Diamondback Energy
FANG
$55.7B
| $572M | 0.17% |
18,997,815
-328,981
| -2% | -$12.5M |
|
127
Citigroup
C
$232B
| $571M | 0.17% |
13,248,179
+7,815,620
| +144% | +$389M |
|
128
Woodward
WWD
$21.3B
| $563M | 0.17% |
7,022,828
+575,414
| +9% | +$46.3M |
|
129
Ultragenyx Pharmaceutical
RARE
$2.6B
| $558M | 0.17% |
6,784,068
+4,503
| +0.1% | +$373K |
|
130
Wyndham Hotels & Resorts
WH
$5.5B
| $554M | 0.17% |
10,963,705
+5,713,726
| +109% | +$279M |
|
131
Telus
TU
$15.1B
| $541M | 0.16% |
30,733,030
+2,710,863
| +10% | +$48.1M |
|
132
PG&E
PCG
$39B
| $540M | 0.16% |
57,479,055
+39,876,796
| +227% | +$369M |
|
133
Principal Financial Group
PFG
$24.6B
| $540M | 0.16% |
13,400,062
+464,232
| +4% | +$19.8M |
|
|
EA
134
DELISTED
Electronic Arts
EA
| $539M | 0.16% |
4,132,456
-625,278
| -13% | -$85.2M |
|
135
DraftKings
DKNG
$12.8B
| $526M | 0.16% |
9,119,365
-33,075
| -0.4% | -$1.29M |
|
136
Marriott International
MAR
$92.7B
| $500M | 0.15% |
5,401,061
-2,377,646
| -31% | -$224M |
|
137
GE Aerospace
GE
$375B
| $499M | 0.15% |
16,063,005
+15,300,586
| +2,007% | +$497M |
|
138
TJX Companies
TJX
$169B
| $495M | 0.15% |
8,903,481
-2,631,992
| -23% | -$142M |
|
139
Aptiv
APTV
$10.1B
| $486M | 0.15% |
5,298,941
+520,319
| +11% | +$43.7M |
|
140
Darden Restaurants
DRI
$25.9B
| $480M | 0.14% |
4,768,253
+2,872,650
| +152% | +$239M |
|
141
Allogene Therapeutics
ALLO
$718M
| $476M | 0.14% |
12,617,992
+609,223
| +5% | +$23M |
|
142
Otis Worldwide
OTIS
$27.8B
| $476M | 0.14% |
7,618,461
-82,041
| -1% | -$5.02M |
|
143
Melco Resorts & Entertainment
MLCO
$2.18B
| $470M | 0.14% |
28,220,542
-8,210,571
| -23% | -$146M |
|
|
CXO
144
DELISTED
CONCHO RESOURCES INC.
CXO
| $469M | 0.14% |
10,628,251
-1,817,446
| -15% | -$90.6M |
|
|
ALLK
145
DELISTED
Allakos
ALLK
| $467M | 0.14% |
5,737,686
+3,288
| +0.1% | +$267K |
|
146
Merck
MRK
$332B
| $464M | 0.14% |
5,855,956
-1,162
| -0% | -$91K |
|
147
TransDigm Group
TDG
$67.4B
| $443M | 0.13% |
931,860
-536,121
| -37% | -$252M |
|
148
Cenovus Energy
CVE
$55.5B
| $440M | 0.13% |
112,996,321
+6,575,741
| +6% | +$30.2M |
|
|
DOCU
149
DocuSign
DOCU
$11.2B
| $440M | 0.13% |
2,044,461
-2,156,878
| -51% | -$448M |
|
|
BLUE
150
DELISTED
bluebird bio
BLUE
| $437M | 0.13% |
625,268
+352
| +0.1% | +$275K |
|
Similar funds
Capital Research Global Investors's Q3 2020 Portfolio in Review
As of Q3 2020, Capital Research Global Investors held 426 positions worth $333B, up 5.4% from $316B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Research Global Investors's Q3 2020 filing shows 27 new, 161 increased, 170 reduced and 21 closed positions. Its largest new stake was Penumbra: 1,572,825 shares worth $306M. The largest sale was Meta Platforms (Facebook), an estimated $2.71B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q3 2020 buy was Penumbra: 1,572,825 shares worth $306M.
- Capital Research Global Investors added most to Comcast in Q3 2020, an estimated $1.85B increase.
- Capital Research Global Investors's biggest Q3 2020 reduction was Meta Platforms (Facebook), cutting an estimated $2.71B.
- Capital Research Global Investors fully exited Simon Property Group in Q3 2020, selling an estimated $245M.
- Capital Research Global Investors's ten largest holdings make up 34% of its $333B portfolio in Q3 2020.
- Capital Research Global Investors opened 27 new positions and closed 21 in Q3 2020.
- Capital Research Global Investors's portfolio value rose 5.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.